Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Reliability of a cognitive endpoint for use in a multiple sclerosis pharmaceutical trial.
Effects of the Anti-Multiple Sclerosis Immunomodulator Laquinimod on Anxiety and Depression in Rodent Behavioral Models.
The VZV/IE63-specific T cell response prevents herpes zoster in fingolimod-treated patients.
Back on the scent: the olfactory system in CNS demyelinating diseases.
Can smoking aggravate my multiple sclerosis symptoms?
Multiple sclerosis-associated retrovirus (MSRV) in Sardinian MS patients.
The validity and reliability of the neurogenic bladder symptom score (NBSS).
Idiopathic inflammatory demyelinating diseases of the central nervous system in patients following allogeneic hematopoietic stem cell transplantation: a retrospective analysis of incidence, risk factors and survival.
Efficacy of minocycline in patients with amyotrophic lateral sclerosis: a phase III randomised trial.
Therapeutic efficacy of IL-17 neutralization in murine experimental autoimmune encephalomyelitis.
CD8+ T-Cell Deficiency, Epstein-Barr Virus Infection, Vitamin D Deficiency, and Steps to Autoimmunity: A Unifying Hypothesis.
Accelerated repair of demyelinated CNS lesions in the absence of non-muscle myosin IIB.
Vitamin D status and ill health: a systematic review.
Riluzole enhances glutamate uptake in rat astrocyte cultures.
▼Dimethyl fumarate for relapsing-remitting multiple sclerosis.
Presumptive Progressive Multifocal Leukoencephalopathy in Multiple Sclerosis after Natalizumab Therapy.
Neuromyelitis optica: clinical manifestations and neuroimaging features.
Rebound of disease activity during pregnancy after withdrawal of fingolimod.
Ustekinumab approved for psoriatic arthritis in US, Europe
In multiple sclerosis oligoclonal bands connect to peripheral B cell responses.
White matter atrophy and cognitive dysfunctions in neuromyelitis optica.
Characterizing contrast-enhancing and re-enhancing lesions in multiple sclerosis.
The pathology of multiple sclerosis.
Post-natalizumab clinical and radiological findings in a cohort of multiple sclerosis patients: 12-month follow-up.
Leukocyte infiltration across the blood-spinal cord barrier is modulated by sleep fragmentation in mice with experimental autoimmune encephalomyelitis.

Pages